Transcatheter arterial chemoembolization in predominantly hepatitis B related Hepatocellular carcinoma: comparison of clip, Okuda and Japan integrated staging in predicting survival

被引:0
|
作者
Cua, I. H. Y. [1 ]
Payawal, D. A. [1 ]
Bocobo, J. C. [1 ]
Cervantes, J. G. [1 ]
Mercado, R. S. [1 ]
Pangilinan, J. A. N. [1 ]
Vallar, R. A. [1 ]
Caluag, J. B. [1 ]
Perez, J. Y. [1 ]
Bondoc, E. M. [1 ]
机构
[1] St Lukes Hosp, Inst Digest Dis, Quezon City, Philippines
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A54 / A54
页数:1
相关论文
共 50 条
  • [21] Improved survival with resection after transcatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma
    Fan, J
    Tang, ZY
    Yu, YQ
    Wu, ZQ
    Ma, ZC
    Zhou, XD
    Zhou, J
    Qiu, SJ
    Lu, JZ
    DIGESTIVE SURGERY, 1998, 15 (06) : 674 - 678
  • [22] Transcatheter arterial chemoembolization confers survival benefit in patients with a spontaneously ruptured hepatocellular carcinoma
    Kim, Jong Yeon
    Lee, June Sung
    Oh, Dong-Hoon
    Yim, Yun Hyuk
    Lee, Hyo Keun
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 24 (06) : 640 - 645
  • [23] A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization
    Lladó, L
    Virgili, J
    Figueras, J
    Valls, C
    Dominguez, J
    Rafecas, A
    Torras, J
    Fabregat, J
    Guardiola, J
    Jaurrieta, E
    CANCER, 2000, 88 (01) : 50 - 57
  • [24] A Hypoxia-Related miRNA-mRNA Signature for Predicting the Response and Prognosis of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma
    Zong, Shaoqi
    Huang, Guokai
    Pan, Bo
    Zhao, Shasha
    Ling, Changquan
    Cheng, Binbin
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 525 - 542
  • [25] Therapy-related myeloid neoplasms after transcatheter arterial chemoembolization for hepatocellular carcinoma
    Yi, Jun Ho
    Jang, Jun Ho
    Jung, Chul Won
    BLOOD RESEARCH, 2021, 56 (04) : 349 - 353
  • [26] Transcatheter arterial chemoembolization for hepatocellular carcinoma: Comparison of the therapeutic efficacies between miriplatin and epirubicin
    Handa, Takahiro
    Imai, Yukinori
    Sugawara, Kayoko
    Chikayama, Taku
    Nakazawa, Manabu
    Ando, Satsuki
    Hamaoka, Kazuhiro
    Inao, Mie
    Nakayama, Nobuaki
    Mochida, Satoshi
    HEPATOLOGY RESEARCH, 2014, 44 (11) : 1072 - 1080
  • [27] Hepatitis B Virus Reactivation Potential Risk Factors in Hepatocellular Carcinoma via Transcatheter Arterial Chemoembolization: A Retrospective Research
    Wang, Xiaoguang
    Yang, Xiaodan
    Chen, Fei
    Wu, Shaohan
    Song, Zhengwei
    Fei, Jianguo
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 2021
  • [28] Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinoma
    Lin, Chia-I
    Lin, Zu-Yau
    Hsieh, Ming-Yen
    Huang, Chung-Feng
    Chen, Su-Hwei
    Chuang, Wan-Long
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2011, 27 (12): : 554 - 559
  • [29] Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan
    Toyoda, H
    Kumada, T
    Kiriyama, S
    Sone, Y
    Tanikawa, M
    Hisanaga, Y
    Yamaguchi, A
    Isogai, M
    Kaneoka, Y
    Washizu, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (08): : 1764 - 1771
  • [30] Coadministration of telaprevir and transcatheter arterial chemoembolization in hepatitis C virus-associated hepatocellular carcinoma
    Harrys A Torres
    Parag Mahale
    Ethan D Miller
    Thein H Oo
    Catherine Frenette
    Ahmed O Kaseb
    World Journal of Hepatology, 2013, (06) : 332 - 335